1. Artemisinin: natural cancer treatment supplement

• Cancer Types: Acute myeloid leukemia (AML), metastatic breast cancer, colorectal carcinoma, and cervical cancer (including HPV-related lesions).

• Food Occurrences: Artemisinin is primarily derived from the herb Sweet Wormwood (Artemisia annua). It does not occur in significant quantities in common conventional foods; it is typically consumed as a medicinal extract or supplement.

• Artemisinin, a sesquiterpene lactone first known for its strong antimalarial effects, is now gaining attention as a potential cancer treatment. It works by reacting with the high iron levels often found in rapidly growing cancer cells, generating reactive oxygen species (ROS) that cause oxidative stress and lead to cell death. Studies show it can slow tumor growth and trigger apoptosis in various cancer types, including leukemia and solid tumors.

• Clinical trials have looked into its use, along with derivatives like artesunate, as a supplement to standard chemotherapy, showing promise in stabilizing metastatic breast and colorectal cancers while offering a better safety profile than typical treatments. Its strong preference for targeting iron-rich cells makes it a unique candidate for targeted therapy.

• Remainder of Report & Sources:

  • Mechanisms: Reversal of multidrug resistance (MDR), induction of ferroptosis, and anti-angiogenic effects.

  • Combinations: Often studied in synergy with resveratrol to enhance apoptotic effects in hepatocellular carcinoma.

  • Primary Source: Cui et al., Chinese Medicine, 2025

  • Additional Source: Frontiers in Immunology

Artemisinin (and Derivatives)

• Primary Food Sources: Sweet Wormwood (Artemisia annua).

• Molecular Targets: Induces iron-dependent oxidative stress (Ferroptosis). It reacts with high intracellular iron levels in cancer cells to generate reactive oxygen species (ROS). It also inhibits the mTOR pathway and downregulates vascular endothelial growth factor (VEGF).

• Bioavailability: Poor water solubility and short half-life in the bloodstream (approx. 2 hours). Nano-encapsulation is currently the primary focus for clinical improvement.

• Cross-Links: * Resveratrol: Shows high synergy in Hepatocellular Carcinoma (liver cancer) and HeLa cells by elevating ROS levels and inducing apoptosis more effectively than either alone.

  • Triptolide: Potentiates growth inhibition in pancreatic cancer models

Home   Facebook